Affordable, accessible and automatic screening solution for diabetic retinopathy

Project Information

Smartscope-X

Grant agreement ID: 778089

DOI 10.3030/778089

Project closed

EC signature date 25 July 2017

Start date 1 August 2017

End date 30 April 2021

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 2 817 050,00

EU contribution € 1 971 935,00

Coordinated by

OPTOMED OY
Finland

Objective

Diabetes is a growing global health concern, affecting 422M people today and the number is projected to rise to 642M by
2040. Over 30 % of diabetics develop a vision-threatening complication called diabetic retinopathy (DR), which is the most
frequent cause of preventable blindness in working-aged adults. DR is diagnosed from retinal images traditionally graded by
an ophthalmologist. Regular eye screenings are the only effective way to detect disease at early stage to prevent visual
impairment or blindness. Hence, globally more than 1 billion screenings would be needed annually. Time, cost and resource efficient screening methods are needed to reach all diabetics.
Finnish Optomed Oy (Ltd.) combines the precision of their handheld fundus camera with an automatic DR grading to
establish Smartscope-X solution. Smartscope-X consists of three main components: a low-cost handheld fundus camera, an
automated screening algorithm and cloud service for fundus images. With this unique combination, Optomed’s vision is to
bring affordable, accessible and automatic DR screening available for all diabetics. In this project, the key ambition is to
validate and commercialise Smartscope-X solution. The project has four objectives: (1) DR algorithm is integrated into
Optomed fundus camera and Optomed Cloud service is developed, (2) clinical validations are conducted, (3) piloting and
commercialisation of the Smartscope-X, with necessary approvals, (4) to establish a data safety and storage system.
Smartscope-X will have a significant impact on visual impairment and blindness prevention in Europe and globally. Today,
significant equipment investment and an experienced grader or ophthalmologist are needed. Hence, DR screening
availability is limited. Smartscope-X user can be trained to use the solution in 1-2 hours. Screening with Smartscope-X will
cost 10 % of current. Therefore, DR screening becomes available to new customers such as endocrinology clinics and even
primary care.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

• engineering and technology › electrical engineering, electronic engineering, information engineering › electronic engineering › sensors › optical sensors
• medical and health sciences › clinical medicine › endocrinology › diabetes
• social sciences › economics and business › business and management › business models
• medical and health sciences › clinical medicine › ophthalmology › retinopathy

You need to log in or register to use this function

Programme(s)

• H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme
• H2020-EU.3.1.4. - Active ageing and self-management of health
• H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
• H2020-EU.3.1.6. - Health care provision and integrated care

Topic(s)

• SMEInst-06-2016-2017 - Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well

Call for proposal

H2020-SMEInst-2016-2017

See other projects for this call

Sub call

H2020-SMEINST-2-2016-2017

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

OPTOMED OY

• Net EU contribution: € 1 852 497,50
• Address: YRTTIPELLONTIE 1 ; 90230 OULU ; Finland
• SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes:
  Region
  Manner-Suomi › Pohjois- ja Itä-Suomi › Pohjois-Pohjanmaa
• Region: Manner-Suomi › Pohjois- ja Itä-Suomi › Pohjois-Pohjanmaa
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Total cost: € 2 817 050,00

Participants (1)

Third-party

Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.

COMMIT OY

Finland

• Net EU contribution: € 119 437,50
• Address: KEILARANTA 16B ; 02150 ESPOO
• SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes:
  Region
  Manner-Suomi › Helsinki-Uusimaa › Helsinki-Uusimaa
• Region: Manner-Suomi › Helsinki-Uusimaa › Helsinki-Uusimaa
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Total cost: € 170 625,00